IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TRIGGIANI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.989
AS - Asia 3.765
EU - Europa 3.473
SA - Sud America 653
Continente sconosciuto - Info sul continente non disponibili 260
AF - Africa 86
OC - Oceania 14
Totale 17.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.710
SG - Singapore 1.309
CN - Cina 1.075
IT - Italia 851
BR - Brasile 509
PL - Polonia 498
DE - Germania 461
HK - Hong Kong 402
UA - Ucraina 387
VN - Vietnam 279
FI - Finlandia 245
GB - Regno Unito 209
FR - Francia 200
BD - Bangladesh 185
RU - Federazione Russa 143
TR - Turchia 140
CA - Canada 125
IN - India 117
BE - Belgio 106
IE - Irlanda 101
MX - Messico 56
ID - Indonesia 46
AR - Argentina 42
ES - Italia 41
IQ - Iraq 40
CZ - Repubblica Ceca 39
NL - Olanda 38
SE - Svezia 31
ZA - Sudafrica 31
EC - Ecuador 30
JP - Giappone 28
LT - Lituania 26
CO - Colombia 25
SA - Arabia Saudita 18
PK - Pakistan 17
VE - Venezuela 17
JM - Giamaica 16
MA - Marocco 16
AT - Austria 15
TT - Trinidad e Tobago 14
GR - Grecia 13
UZ - Uzbekistan 13
AU - Australia 12
DZ - Algeria 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
CR - Costa Rica 10
SV - El Salvador 10
PR - Porto Rico 9
BO - Bolivia 8
CL - Cile 8
EG - Egitto 8
HU - Ungheria 8
TN - Tunisia 8
EE - Estonia 7
IL - Israele 7
PY - Paraguay 7
AZ - Azerbaigian 6
CW - ???statistics.table.value.countryCode.CW??? 6
EU - Europa 6
GP - Guadalupe 6
GT - Guatemala 6
JO - Giordania 6
PH - Filippine 6
TH - Thailandia 6
CH - Svizzera 5
KH - Cambogia 5
LB - Libano 5
MY - Malesia 5
NI - Nicaragua 5
NP - Nepal 5
PT - Portogallo 5
AM - Armenia 4
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
CY - Cipro 3
IR - Iran 3
KR - Corea 3
OM - Oman 3
PA - Panama 3
TW - Taiwan 3
BG - Bulgaria 2
BS - Bahamas 2
BZ - Belize 2
GD - Grenada 2
GY - Guiana 2
HR - Croazia 2
HT - Haiti 2
IS - Islanda 2
KE - Kenya 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 16.964
Salva come PNG Salva come JPEG
Città #
Ashburn 983
Singapore 712
Fairfield 701
San Jose 541
Warsaw 489
Woodbridge 443
Hong Kong 397
Houston 354
Seattle 315
Chandler 312
New York 298
Cambridge 288
Jacksonville 286
Council Bluffs 260
Wilmington 244
Beijing 237
The Dalles 233
Los Angeles 222
Helsinki 192
Ann Arbor 189
Dallas 174
Princeton 166
Dearborn 146
Brescia 129
Munich 121
Istanbul 104
Lauterbourg 103
Dublin 98
Ho Chi Minh City 93
Leuven 90
Santa Clara 89
Milan 87
Shanghai 82
Nanjing 74
San Francisco 60
Columbus 55
Buffalo 54
Des Moines 51
São Paulo 50
North Bergen 48
Chicago 46
Dong Ket 46
Moscow 45
Boardman 43
Hanoi 42
Redondo Beach 42
Frankfurt am Main 39
Orem 39
San Diego 39
Phoenix 38
London 36
Washington 36
Denver 35
Montreal 35
Jakarta 33
Chennai 32
Brooklyn 31
Brno 29
Nanchang 29
Turku 29
Shenyang 28
Changsha 25
Nuremberg 24
Jinan 23
Naples 23
Toronto 23
Atlanta 22
Boston 22
Tokyo 22
Mexico City 21
Poplar 21
Rome 21
Hebei 20
Verona 19
Zhengzhou 19
Johannesburg 18
Baghdad 17
Newark 17
Vilnius 17
Brussels 16
Kunming 16
Rio de Janeiro 16
Tianjin 16
Bari 15
Romola 15
Quito 14
Stockholm 14
Bologna 13
Haiphong 13
Jiaxing 13
Lancaster 13
Athens 12
Barcelona 12
Brasília 12
Charlotte 12
Da Nang 12
Florence 12
Hangzhou 12
New Delhi 12
Ningbo 12
Totale 10.998
Salva come PNG Salva come JPEG
Nome #
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 314
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 282
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 271
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 268
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 260
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 242
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 237
Pros-IT CNR: an Italian prostate cancer monitoring project 230
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 227
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 222
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 222
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 221
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 218
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 216
GUROPA survey: genito-urinary radiation oncology prescription attitudes 202
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 200
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 198
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 195
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 195
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 186
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 186
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 185
From Molecular to Clinical Radiation Biology of Glioblastoma 183
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 182
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 182
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 181
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 181
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 179
Role of external beam radiotherapy in the treatment of relapsing meningioma 179
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 179
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 178
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 177
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 175
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 175
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 174
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 174
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 172
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 172
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 169
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 169
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 168
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 166
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 166
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 163
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 158
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 157
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 156
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 153
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 153
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 152
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 151
Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy 151
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 148
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 148
Cetuximab and Radiation Therapy in Head and Neck Cancer 148
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 147
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 147
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 146
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 146
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 145
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 143
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 141
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 140
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 139
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 138
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 136
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 134
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 132
Applying radiation protection and safety in radiotherapy 131
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 131
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 126
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 126
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 125
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 123
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 122
Letter to the editor regarding “Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable” 119
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 118
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 117
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 117
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 117
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 116
The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT) 114
Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP) 111
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 111
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 110
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 106
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 105
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 104
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 102
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 102
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 100
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 100
SBRT in Lymph-Nodal Oligometastases from Prostate Cancer: Different Outcomes between Pelvic and Para-Aortic Disease 98
Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation 97
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START) 96
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 94
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group 93
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 93
Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature 93
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 92
Totale 15.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022560 0 0 0 28 12 49 31 67 39 83 38 213
2022/2023878 97 35 34 52 90 186 13 106 157 5 64 39
2023/20241.371 69 28 165 75 71 302 50 89 206 49 65 202
2024/20252.275 33 35 29 340 180 208 190 117 249 160 449 285
2025/20265.522 516 610 388 714 619 361 800 206 382 472 253 201
2026/20271.569 179 252 373 765 0 0 0 0 0 0 0 0
Totale 17.240